Back to Search
TIFFANY HARDY, MDIV
MDIV
Pastoral Counselor
NPI: 1902991524Individual
Specialties, Licenses & Credentials
Pastoral CounselorPrimary
Counselor — Pastoral
Code: 101YP1600X
Research & Publications (20)
Randomized trial of a behavioral weight loss intervention for low-income women: the Weight Wise Program.
PMID 19407810·Obesity (Silver Spring)·2009
2-rct
The Xpc gene markedly affects cell survival in mouse bone marrow.
PMID 19372135·Mutagenesis·2009
7-preclinical
Influence of patient head positioning on measured axial tooth inclination in panoramic radiography.
PMID 19487740·J Orthod·2009
4-observational
Use of the orbicularis retaining ligament in lower eyelid reconstruction.
PMID 18434271·J Plast Reconstr Aesthet Surg·2009
4-observational
Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder.
PMID 19209252·Ther Clin Risk Manag·2008
8-other
Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder.
PMID 18793440·BMC Psychiatry·2008
8-other
Weight changes during treatment with olanzapine in older adult patients with dementia and behavioral disturbances.
PMID 17548781·J Geriatr Psychiatry Neurol·2007
1-meta
C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy.
PMID 17660820·Nat Genet·2007
8-other
Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks.
PMID 17192353·Diabetes Care·2007
2-rct
Does treatment with duloxetine for neuropathic pain impact glycemic control?
PMID 17192327·Diabetes Care·2007
8-other
Early predictors of substantial weight gain in bipolar patients treated with olanzapine.
PMID 16702898·J Clin Psychopharmacol·2006
2-rct
Inhibition of Escherichia coli heat-labile enterotoxin B subunit pentamer (EtxB5) assembly in vitro using monoclonal antibodies.
PMID 17038315·J Biol Chem·2006
7-preclinical
A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects.
PMID 16860171·Clin Ther·2006
2-rct
Cross-sectional comparison of fasting lipids in normoglycemic patients with schizophrenia during chronic treatment with olanzapine, risperidone, or typical antipsychotics.
PMID 16855460·J Clin Psychopharmacol·2006
4-observational
The effects of demineralized bone matrix proteins and osteogenic protein-1 on bone cells isolated in culture.
PMID 16817587·Biomed Sci Instrum·2006
4-observational
Retrospective analysis of diabetes risk in elderly patients with dementia in olanzapine clinical trials.
PMID 16407583·Am J Geriatr Psychiatry·2006
8-other
Synthetic vision systems: the effects of guidance symbology, display size, and field of view.
PMID 16553060·Hum Factors·2005
8-other
The Metabolic Syndrome in Patients With Severe Mental Illnesses.
PMID 15361918·Prim Care Companion J Clin Psychiatry·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5500 ARMSTRONG RD, VA MEDICAL CENTER (115A)
BATTLE CREEK, MI 49015 - Phone
- (269) 966-5600
Quick Facts
- NPI
- 1902991524
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile